Association of Gestational Free and Total Triiodothyronine With Gestational Hypertension, Preeclampsia, Preterm Birth, and Birth Weight: An Individual Participant Data Meta-analysis: An Individual Participant Data Meta-analysis
Gespeichert in:
| Titel: | Association of Gestational Free and Total Triiodothyronine With Gestational Hypertension, Preeclampsia, Preterm Birth, and Birth Weight: An Individual Participant Data Meta-analysis: An Individual Participant Data Meta-analysis |
|---|---|
| Autoren: | Arash Derakhshan, Tuija Männistö, Liangmiao Chen, Joris A J Osinga, Ghalia Ashoor, Xuemian Lu, Sofie Bliddal, Fang-Biao Tao, Suzanne J Brown, Bijay Vaidya, Andrew T Hattersley, Sachiko Itoh, Polina V Popova, Ashraf Aminorroaya, Reiko Kishi, Maryam Kianpour, Elena A Vasukova, Abel López-Bermejo, Emily Oken, Leda Chatzi, Marina Vafeiadi, Wichor M Bramer, Judit Bassols, Aitana Lertxundi, Ana Fernández-Somoano, Paula Carrasco, Juha Auvinen, Kun Huang, Ulla Feldt-Rasmussen, Elena N Grineva, Erik K Alexander, Elizabeth N Pearce, Layal Chaker, John P Walsh, Robin P Peeters, Mònica Guxens, Eila Suvanto, Kypros H Nicolaides, Tim I M Korevaar |
| Quelle: | J Clin Endocrinol Metab JOURNAL OF CLINICAL ENDOCRINOLOGY & METABOLISM r-FISABIO. Repositorio Institucional de Producción Científica Fundación para el Fomento de la Investigación Sanitaria y Biomédica de la Comunitat Valenciana (FISABIO) Derakhshan, A, Männistö, T, Chen, L, Osinga, J A J, Ashoor, G, Lu, X, Bliddal, S, Tao, F-B, Brown, S J, Vaidya, B, Hattersley, A T, Itoh, S, Popova, P V, Aminorroaya, A, Kishi, R, Kianpour, M, Vasukova, E A, López-Bermejo, A, Oken, E, Chatzi, L, Vafeiadi, M, Bramer, W M, Bassols, J, Lertxundi, A, Fernández-Somoano, A, Carrasco, P, Auvinen, J, Huang, K, Feldt-Rasmussen, U, Grineva, E N, Alexander, E K, Pearce, E N, Chaker, L, Walsh, J P, Peeters, R P, Guxens, M, Suvanto, E, Nicolaides, K H & Korevaar, T I M 2024, ' Association of Gestational Free and Total Triiodothyronine With Gestational Hypertension, Preeclampsia, Preterm Birth, and Birth Weight : An Individual Participant Data Meta-analysis ', The Journal of clinical endocrinology and metabolism, vol. 109, no. 3, pp. e1290-e1298 . https://doi.org/10.1210/clinem/dgad631 |
| Verlagsinformationen: | The Endocrine Society, 2023. |
| Publikationsjahr: | 2023 |
| Schlagwörter: | Thyroid Hormones, Pre-Eclampsia/epidemiology, Thyrotropin, preeclampsia, SDG 3 - Good Health and Well-being, Pre-Eclampsia, Pregnancy, triiodothyronine, gestational hypertension, Humans, Birth Weight, Prospective Studies, Infant, Newborn, Infant, preterm birth, birth weight, Hypertension, Pregnancy-Induced, Newborn, 3. Good health, Thyroxine, Premature Birth/epidemiology, Pregnancy-Induced/epidemiology, Hypertension, Triiodothyronine, Premature Birth, Female, pregnancy, Hypertension, Pregnancy-Induced/epidemiology, Meta-Analysis |
| Beschreibung: | Context Triiodothyronine (T3) is the bioactive form of thyroid hormone. In contrast to thyroid-stimulating hormone and free thyroxine, we lack knowledge on the association of gestational T3 with adverse obstetric outcomes. Objective To investigate the associaiton of gestational free or total T3 (FT3 or TT3) with adverse obstetric outcomes. Methods We collected individual participant data from prospective cohort studies on gestational FT3 or TT3, adverse obstetric outcomes (preeclampsia, gestational hypertension, preterm birth and very preterm birth, small for gestational age [SGA], and large for gestational age [LGA]), and potential confounders. We used mixed-effects regression models adjusting for potential confounders. Results The final study population comprised 33 118 mother–child pairs of which 27 331 had data on FT3 and 16 164 on TT3. There was a U-shaped association of FT3 with preeclampsia (P = .0069) and a J-shaped association with the risk of gestational hypertension (P = .029). Higher TT3 was associated with a higher risk of gestational hypertension (OR per SD of TT3 1.20, 95% CI 1.08 to 1.33; P = .0007). A lower TT3 but not FT3 was associated with a higher risk of very preterm birth (OR 0.72, 95% CI 0.55 to 0.94; P = .018). TT3 but not FT3 was positively associated with birth weight (mean difference per 1 SD increase in TT3 12.8, 95% CI 6.5 to 19.1 g, P < .0001) but there was no association with SGA or LGA. Conclusion This study provides new insights on the association of gestational FT3 and TT3 with major adverse pregnancy outcomes that form the basis for future studies required to elucidate the effects of thyroid function on pregnancy outcomes. Based on the current study, routine FT3 or TT3 measurements for the assessment of thyroid function during pregnancy do not seem to be of added value in the risk assessment for adverse outcomes. |
| Publikationsart: | Article Other literature type |
| Dateibeschreibung: | application/pdf |
| Sprache: | English |
| ISSN: | 1945-7197 0021-972X |
| DOI: | 10.1210/clinem/dgad631 |
| Zugangs-URL: | https://pubmed.ncbi.nlm.nih.gov/37878891 https://fisabio.portalinvestigacion.com/publicaciones/15780 https://curis.ku.dk/ws/files/386612998/dgad631.pdf |
| Rights: | CC BY URL: http://creativecommons.org/licenses/by/4.0/This is an Open Access article distributed under the terms of the Creative Commons Attribution License (http://creativecommons.org/licenses/by/4.0/), which permits unrestricted reuse, distribution, and reproduction in any medium, provided the original work is properly cited. |
| Dokumentencode: | edsair.doi.dedup.....cd3c491db227c305de50d8b6b3003a99 |
| Datenbank: | OpenAIRE |
Full Text Finder 
Nájsť tento článok vo Web of Science | Abstract: | Context Triiodothyronine (T3) is the bioactive form of thyroid hormone. In contrast to thyroid-stimulating hormone and free thyroxine, we lack knowledge on the association of gestational T3 with adverse obstetric outcomes. Objective To investigate the associaiton of gestational free or total T3 (FT3 or TT3) with adverse obstetric outcomes. Methods We collected individual participant data from prospective cohort studies on gestational FT3 or TT3, adverse obstetric outcomes (preeclampsia, gestational hypertension, preterm birth and very preterm birth, small for gestational age [SGA], and large for gestational age [LGA]), and potential confounders. We used mixed-effects regression models adjusting for potential confounders. Results The final study population comprised 33 118 mother–child pairs of which 27 331 had data on FT3 and 16 164 on TT3. There was a U-shaped association of FT3 with preeclampsia (P = .0069) and a J-shaped association with the risk of gestational hypertension (P = .029). Higher TT3 was associated with a higher risk of gestational hypertension (OR per SD of TT3 1.20, 95% CI 1.08 to 1.33; P = .0007). A lower TT3 but not FT3 was associated with a higher risk of very preterm birth (OR 0.72, 95% CI 0.55 to 0.94; P = .018). TT3 but not FT3 was positively associated with birth weight (mean difference per 1 SD increase in TT3 12.8, 95% CI 6.5 to 19.1 g, P < .0001) but there was no association with SGA or LGA. Conclusion This study provides new insights on the association of gestational FT3 and TT3 with major adverse pregnancy outcomes that form the basis for future studies required to elucidate the effects of thyroid function on pregnancy outcomes. Based on the current study, routine FT3 or TT3 measurements for the assessment of thyroid function during pregnancy do not seem to be of added value in the risk assessment for adverse outcomes. |
|---|---|
| ISSN: | 19457197 0021972X |
| DOI: | 10.1210/clinem/dgad631 |